These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 16220518)

  • 1. Tutorial in biostatistics: the self-controlled case series method.
    Whitaker HJ; Farrington CP; Spiessens B; Musonda P
    Stat Med; 2006 May; 25(10):1768-97. PubMed ID: 16220518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample sizes for self-controlled case series studies.
    Musonda P; Farrington CP; Whitaker HJ
    Stat Med; 2006 Aug; 25(15):2618-31. PubMed ID: 16372391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R;
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral polio vaccine and intussusception: a data linkage study using records for vaccination and hospitalization.
    Cameron JC; Walsh D; Finlayson AR; Boyd JH
    Am J Epidemiol; 2006 Mar; 163(6):528-33. PubMed ID: 16467416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward better vaccine safety data and safer vaccination.
    Braun MM
    Pediatrics; 2008 Mar; 121(3):625-6. PubMed ID: 18310214
    [No Abstract]   [Full Text] [Related]  

  • 6. Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design.
    Park T; Ki M; Yi SG
    Stat Med; 2004 Jun; 23(12):1871-83. PubMed ID: 15195321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture model.
    Berry SM; Berry DA
    Biometrics; 2004 Jun; 60(2):418-26. PubMed ID: 15180667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative incidence estimation from case series for vaccine safety evaluation.
    Farrington CP
    Biometrics; 1995 Mar; 51(1):228-35. PubMed ID: 7766778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying optimal risk windows for self-controlled case series studies of vaccine safety.
    Xu S; Zhang L; Nelson JC; Zeng C; Mullooly J; McClure D; Glanz J
    Stat Med; 2011 Mar; 30(7):742-52. PubMed ID: 21394750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methodology of self-controlled case series studies.
    Whitaker HJ; Hocine MN; Farrington CP
    Stat Methods Med Res; 2009 Feb; 18(1):7-26. PubMed ID: 18562396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case series analysis for censored, perturbed, or curtailed post-event exposures.
    Farrington CP; Whitaker HJ; Hocine MN
    Biostatistics; 2009 Jan; 10(1):3-16. PubMed ID: 18499654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
    Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
    Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination associated thrombocytopenic purpura in children.
    Rajantie J; Zeller B; Treutiger I; Rosthöj S;
    Vaccine; 2007 Feb; 25(10):1838-40. PubMed ID: 17126957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mixture model with detection limits for regression analyses of antibody response to vaccine.
    Moulton LH; Halsey NA
    Biometrics; 1995 Dec; 51(4):1570-8. PubMed ID: 8589241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis.
    Lee KJ; Carlin JB
    Stat Med; 2014 Jan; 33(1):105-16. PubMed ID: 23868284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling drop-out in longitudinal studies.
    Hogan JW; Roy J; Korkontzelou C
    Stat Med; 2004 May; 23(9):1455-97. PubMed ID: 15116353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.